Metformin for aging people with MS
Treatments studied
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests whether metformin, a common diabetes drug, can help people with multiple sclerosis (MS) as they age. It may be used alone or added to your current MS treatment, and the goal is to see if it slows down aging-related changes in MS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 55 and 75 years old.
- You have been diagnosed with multiple sclerosis (MS).
- Your MS has been stable (no relapses or new MRI changes) for the past 2 years.
- You are able to walk without a walker or wheelchair most of the time (EDSS score less than 7).
- You do not have diabetes or uncontrolled heart disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how exercise affects muscle health in people aged 60 or older with multiple sclerosis. It may help you understand if a structured exercise program can improve your strength and mobility.
This study tests whether metformin can help “reset” damaged nerve cells in the brain and improve vision-related nerve problems in children and young adults with multiple sclerosis. Participants are assigned to metformin or a comparison treatment in a blinded (not everyone knows which) study.
This trial tests whether metformin can help adults with intellectual disability who gained weight from long-term antipsychotic medicines. If you qualify, you may be assigned metformin to improve weight and related health measures.
This study tests whether metformin can help slow aging in healthy men. You might be eligible if you are a man in one of two age groups and do not have major health problems.
This trial tests if metformin can help older adults (60-75) who are overweight and have mild memory problems. It aims to see if the drug can slow down or improve memory issues.
This study tests if the diabetes drug metformin can slow down aging-related lung decline in people with COPD. You may qualify if you have moderate-to-severe COPD with emphysema and a history of smoking.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.